Northstar Wealth Partners’s Gilead Sciences GILD Stock Holding History

Northstar Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,771	Closed	-$213K	–	160
2020 Q2	$213K	Sell	2,771 -520	-16%	-$39.9K	0.09%	166
2020 Q1	$246K	Sell	3,291 -4,050	-55%	-$280K	0.13%	137
2019 Q4	$477K	Hold	7,341	–	–	0.2%	116
2019 Q3	$465K	Hold	7,341	–	–	0.2%	115
2019 Q2	$496K	Buy	7,341 +475	+7%	+$31.2K	0.22%	111
2019 Q1	$446K	Hold	6,866	–	–	0.2%	112
2018 Q4	$429K	Buy	6,866 +6	+0.1%	+$419	0.23%	108
2018 Q3	$529K	Hold	6,860	–	–	0.25%	102
2018 Q2	$485K	Sell	6,860 -1,165	-15%	-$82.3K	0.24%	113
2018 Q1	$605K	Buy	+8,025	New	+$638K	0.31%	96

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northstar Wealth Partners's GILD Position: Q3 2020 in Review

Northstar Wealth Partners sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,771 shares — an estimated $213K sold.

Northstar Wealth Partners first reported a position in GILD in Q1 2018 and held it in 10 quarters. The position peaked at $605K in Q1 2018. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Northstar Wealth Partners reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Northstar Wealth Partners sold 2,771 Gilead Sciences shares in Q3 2020, an estimated $213K.
Northstar Wealth Partners first reported a position in Gilead Sciences in Q1 2018 and held it in 10 quarters.
Northstar Wealth Partners's Gilead Sciences position peaked at $605K in Q1 2018.
1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.